Please wait while the formulary information is being retrieved.
TAMIFLU (OSELTAMIVIR PHOSPHATE)
- Influenza
- Influenza prevention
6 mg/mL oral suspension
- 12.5 milliliters (75 mg) by oral route 2 times per day
6 mg/mL oral suspension
- 12.5 milliliters (75 mg) by oral route 2 times per day
oseltamivir 6 mg/mL oral suspension
- 12.5 milliliters (75 mg) by oral route 2 times per day
Influenza
- 12.5 milliliters (75 mg) by oral route 2 times per day
- 12.5 milliliters (75 mg) by oral route 2 times per day for 5 days
Influenza prevention
- 12.5 milliliters (75 mg) by oral route once daily
- 12.5 milliliters (75 mg) by oral route once daily for 10 days
- 12.5 milliliters (75 mg) by oral route once daily for 7 days
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
Contraindicated
- None
Severe
Moderate
- clopidogrel
- Plavix
- None
Contraindicated
- Chronic kidney disease stage 3A (moderate) GFR 45-59
- Chronic kidney disease stage 3B (moderate) GFR 30-44
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
Severe
Moderate
- Acute confusion
- Delirium
- Kidney disease with likely reduction in GFR
- Suicidal ideation
TAMIFLU (OSELTAMIVIR PHOSPHATE)
- Influenza
- Influenza prevention
- None
- Headache disorder
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- None
- Diarrhea
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Accidental injury
- Acute confusion
- Anaphylaxis
- Behavioral disorders
- Cardiac arrhythmia
- Delirium
- Erythema multiforme
- Facial edema
- Gastrointestinal hemorrhage
- Hallucinations
- Hemorrhagic colitis
- Hepatitis
- Hypothermia
- Seizure disorder
- Stevens-johnson syndrome
- Tongue swelling
- Toxic epidermal necrolysis
- Urticaria
Less Severe
- Agitation
- Allergic dermatitis
- Delusional disorder
- Eczema
- Nightmares
- Pain
- Skin inflammation
- Skin rash
- Symptoms of anxiety
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Oseltamivir
Safety and efficacy not established age < 2 weeks. Risk of vomiting, diarrhea, behavioral changes.
Monitor for abnormal behavior. Possible risk of confusion, hallucination and seizure. Nausea and vomiting more common age < 1 year.
- 1 Day – 13 Days
- Safety and efficacy not established age < 2 weeks. Risk of vomiting, diarrhea, behavioral changes.
- Monitor for abnormal behavior. Possible risk of confusion, hallucination and seizure. Nausea and vomiting more common age < 1 year.
- 14 Days – 18 Years
- Safety and efficacy not established age < 2 weeks. Risk of vomiting, diarrhea, behavioral changes.
- Monitor for abnormal behavior. Possible risk of confusion, hallucination and seizure. Nausea and vomiting more common age < 1 year.
Oseltamivir
- Severity Level:
2
- Additional Notes: Limited epidemiological studies suggest no increased risk of birth defects.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Oseltamivir
Cdc rec continuing breastfeeding during antiviral treatment or prophylaxis
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Cdc rec continuing breastfeeding during antiviral treatment or prophylaxis |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Influenza | |
| J09 | Influenza due to certain identified influenza viruses |
| J09.x | Influenza due to identified novel influenza A virus |
| J09.x1 | Influenza due to identified novel influenza A virus with pneumonia |
| J09.x2 | Influenza due to identified novel influenza A virus with other respiratory manifestations |
| J09.x3 | Influenza due to identified novel influenza A virus with gastrointestinal manifestations |
| J09.x9 | Influenza due to identified novel influenza A virus with other manifestations |
| J10 | Influenza due to other identified influenza virus |
| J10.0 | Influenza due to other identified influenza virus with pneumonia |
| J10.00 | Influenza due to other identified influenza virus with unspecified type of pneumonia |
| J10.01 | Influenza due to other identified influenza virus with the same other identified influenza virus pneumonia |
| J10.08 | Influenza due to other identified influenza virus with other specified pneumonia |
| J10.1 | Influenza due to other identified influenza virus with other respiratory manifestations |
| J10.2 | Influenza due to other identified influenza virus with gastrointestinal manifestations |
| J10.8 | Influenza due to other identified influenza virus with other manifestations |
| J10.81 | Influenza due to other identified influenza virus with encephalopathy |
| J10.82 | Influenza due to other identified influenza virus with myocarditis |
| J10.83 | Influenza due to other identified influenza virus with otitis media |
| J10.89 | Influenza due to other identified influenza virus with other manifestations |
| J11 | Influenza due to unidentified influenza virus |
| J11.0 | Influenza due to unidentified influenza virus with pneumonia |
| J11.00 | Influenza due to unidentified influenza virus with unspecified type of pneumonia |
| J11.08 | Influenza due to unidentified influenza virus with specified pneumonia |
| J11.1 | Influenza due to unidentified influenza virus with other respiratory manifestations |
| J11.2 | Influenza due to unidentified influenza virus with gastrointestinal manifestations |
| J11.8 | Influenza due to unidentified influenza virus with other manifestations |
| J11.81 | Influenza due to unidentified influenza virus with encephalopathy |
| J11.82 | Influenza due to unidentified influenza virus with myocarditis |
| J11.83 | Influenza due to unidentified influenza virus with otitis media |
| J11.89 | Influenza due to unidentified influenza virus with other manifestations |
| Influenza prevention | |
| Z23 | Encounter for immunization |
| 0-9 | A-Z |
|---|---|
| J09 | Influenza due to certain identified influenza viruses |
| J09.x | Influenza due to identified novel influenza A virus |
| J09.x1 | Influenza due to identified novel influenza A virus with pneumonia |
| J09.x2 | Influenza due to identified novel influenza A virus with other respiratory manifestations |
| J09.x3 | Influenza due to identified novel influenza A virus with gastrointestinal manifestations |
| J09.x9 | Influenza due to identified novel influenza A virus with other manifestations |
| J10 | Influenza due to other identified influenza virus |
| J10.0 | Influenza due to other identified influenza virus with pneumonia |
| J10.00 | Influenza due to other identified influenza virus with unspecified type of pneumonia |
| J10.01 | Influenza due to other identified influenza virus with the same other identified influenza virus pneumonia |
| J10.08 | Influenza due to other identified influenza virus with other specified pneumonia |
| J10.1 | Influenza due to other identified influenza virus with other respiratory manifestations |
| J10.2 | Influenza due to other identified influenza virus with gastrointestinal manifestations |
| J10.8 | Influenza due to other identified influenza virus with other manifestations |
| J10.81 | Influenza due to other identified influenza virus with encephalopathy |
| J10.82 | Influenza due to other identified influenza virus with myocarditis |
| J10.83 | Influenza due to other identified influenza virus with otitis media |
| J10.89 | Influenza due to other identified influenza virus with other manifestations |
| J11 | Influenza due to unidentified influenza virus |
| J11.0 | Influenza due to unidentified influenza virus with pneumonia |
| J11.00 | Influenza due to unidentified influenza virus with unspecified type of pneumonia |
| J11.08 | Influenza due to unidentified influenza virus with specified pneumonia |
| J11.1 | Influenza due to unidentified influenza virus with other respiratory manifestations |
| J11.2 | Influenza due to unidentified influenza virus with gastrointestinal manifestations |
| J11.8 | Influenza due to unidentified influenza virus with other manifestations |
| J11.81 | Influenza due to unidentified influenza virus with encephalopathy |
| J11.82 | Influenza due to unidentified influenza virus with myocarditis |
| J11.83 | Influenza due to unidentified influenza virus with otitis media |
| J11.89 | Influenza due to unidentified influenza virus with other manifestations |
| Z23 | Encounter for immunization |
Formulary Reference Tool